Literature DB >> 21822871

Xeno-free culture of human pluripotent stem cells.

Rosita Bergström1, Susanne Ström, Frida Holm, Anis Feki, Outi Hovatta.   

Abstract

Stem cell culture systems that rely on undefined animal-derived components introduce variability to the cultures and complicate their therapeutic use. The derivation of human embryonic stem cells and the development of methods to produce induced pluripotent stem cells combined with their potential to treat human diseases have accelerated the drive to develop xenogenic-free, chemically defined culture systems that support pluripotent self-renewal and directed differentiation. In this chapter, we describe four xeno-free culture systems that have been successful in supporting undifferentiated growth of hPSCs as well as methods for xeno-free subculture and cryopreservation of hPSCs. Each culture system consists of a xeno-free growth medium and xeno-free substratum: (1) TeSR2™ with human recombinant laminin (LN-511); (2) NutriStem™ with LN-511; (3) RegES™ with human foreskin fibroblasts (hFFs); (4) KO-SR Xeno-Free™/GF cocktail with CELLstart™ matrix.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21822871     DOI: 10.1007/978-1-61779-201-4_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  18 in total

1.  Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment.

Authors:  Emma Stephenson; Laureen Jacquet; Cristian Miere; Victoria Wood; Neli Kadeva; Glenda Cornwell; Stefano Codognotto; Yaser Dajani; Peter Braude; Dusko Ilic
Journal:  Nat Protoc       Date:  2012-06-21       Impact factor: 13.491

Review 2.  Methods of induced pluripotent stem cells for clinical application.

Authors:  Tomohisa Seki; Keiichi Fukuda
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

Review 3.  Potential of pluripotent stem cells for diabetes therapy.

Authors:  Insa S Schroeder
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

Review 4.  Application of stem cell-derived retinal pigmented epithelium in retinal degenerative diseases: present and future.

Authors:  Mingyue Luo; Youxin Chen
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

5.  Process-based expansion and neural differentiation of human pluripotent stem cells for transplantation and disease modeling.

Authors:  Alexander E Stover; David J Brick; Hubert E Nethercott; Maria G Banuelos; Lei Sun; Diane K O'Dowd; Philip H Schwartz
Journal:  J Neurosci Res       Date:  2013-07-26       Impact factor: 4.164

Review 6.  A decade of transcription factor-mediated reprogramming to pluripotency.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Nat Rev Mol Cell Biol       Date:  2016-02-17       Impact factor: 94.444

7.  Efficient generation of functional epithelial and epidermal cells from human pluripotent stem cells under defined conditions.

Authors:  Joshua A Selekman; Nicholas J Grundl; Joshua M Kolz; Sean P Palecek
Journal:  Tissue Eng Part C Methods       Date:  2013-06-04       Impact factor: 3.056

8.  Decellularized feeders: an optimized method for culturing pluripotent cells.

Authors:  Mei Ling Lim; Philipp Jungebluth; Sebastian Sjöqvist; Hero Nikdin; Kristín Rós Kjartansdóttir; Christian Unger; Ivan Vassliev; Paolo Macchiarini
Journal:  Stem Cells Transl Med       Date:  2013-10-28       Impact factor: 6.940

9.  Nonxenogeneic growth and retinal differentiation of human induced pluripotent stem cells.

Authors:  Akshayalakshmi Sridhar; Melissa M Steward; Jason S Meyer
Journal:  Stem Cells Transl Med       Date:  2013-03-19       Impact factor: 6.940

10.  Engineering cell-material interfaces for long-term expansion of human pluripotent stem cells.

Authors:  Chien-Wen Chang; Yongsung Hwang; Dave Brafman; Thomas Hagan; Catherine Phung; Shyni Varghese
Journal:  Biomaterials       Date:  2012-11-03       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.